Every Form 4 that Petvivo Hldgs Inc (PETV) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PETV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PETV filings page.
PetVivo Holdings, Inc. (PETV) reported that Chief Financial Officer Garry N. Lowenthal, through a corporation he owns, participated in a private placement investment. On September 8, 2026, a warrant to acquire 31,250 shares of common stock at an exercise price of $1.10 per share was converted into common stock, and the corporation simultaneously acquired 31,250 shares of restricted common stock at $0.80 per share in connection with the same investment under a subscription agreement. Following these transactions, the corporation indirectly owned 985,131 shares of PetVivo common stock. No transactions were made under a Rule 10b5-1 trading plan.
PetVivo Holdings, Inc. (PETV) reported that its Chief Executive Officer and director John Lai acquired 31,250 shares of restricted common stock on September 9, 2026 at $0.78 per share in connection with a private placement investment pursuant to a subscription agreement. In a related step, on September 8–9, 2026 he converted warrants covering 31,250 shares of common stock at an exercise price of $1.10 per share, with the warrants scheduled to expire on September 9, 2029. Following these transactions, he directly holds 2,413,163 shares of PetVivo common stock. No transactions were reported under a Rule 10b5-1 trading plan.
PetVivo Holdings, Inc. reported that Chief Financial Officer Garry N. Lowenthal indirectly acquired 75,000 shares of restricted common stock on 2026-07-21 at $0.77 per share. The grant was issued to a corporation he owns as compensation for past performance, bringing his indirect "By Corporation" holdings to 953,881 shares.
Lai John reported acquisition or exercise transactions in this Form 4 filing.
PetVivo Holdings, Inc. reported that Chief Executive Officer John Lai, through a corporation he owns, received a grant of 75,000 shares of restricted common stock on July 21, 2026 at $0.77 per share as compensation for past performance, increasing his indirectly held common stock to 2,381,913 shares.
PetVivo Holdings, Inc. major holder A.L. Sarroff Fund, LLC reported open-market purchases tied to unit financing. The fund bought 187,500 shares of Common Stock and 187,500 Warrants, with each Unit priced at $0.80 and consisting of one share plus one Warrant.
The Warrants allow purchase of 187,500 shares of Common Stock at an exercise price of $1.10 per share until June 9, 2036. Following the transactions, the fund holds 10,439,729 shares of Common Stock and 187,500 Warrants directly, indicating a modest incremental increase in its position.
A.L. Sarroff Fund, LLC, a 10% owner of PetVivo Holdings, Inc., reported a bona fide gift transfer of 200,000 shares of common stock on May 28, 2026. The transfer was recorded at $0.00 per share, and the fund now directly holds 10,252,229 shares. Alan L. Sarroff, as Chief Executive Officer and Managing Member of the fund, is deemed to beneficially own these securities with sole voting and dispositive power.
PetVivo Holdings, Inc. saw its significant shareholder A.L. Sarroff Fund, LLC make an open-market purchase of common stock. On May 22, 2026, the fund bought 250,000 shares at 0.40 per share, increasing its direct holdings to 10,452,229 shares.
Alan L. Sarroff, as Chief Executive Officer and Managing Member of A.L. Sarroff Fund, is deemed to beneficially own these securities and to have sole voting and dispositive power over them. This transaction modestly increases an already large position in the company.
PetVivo Holdings, Inc. reported that its Chief Financial Officer, Garry N. Lowenthal, indirectly acquired 66,421 shares of common stock as a grant of restricted stock. The award was made to a corporation owned by him as compensation for his past performance at an implied price of $0.72 per share.
Following this grant, the filing shows 878,881 shares of common stock held indirectly through the corporation. This is a compensation-related, non-market transaction rather than an open-market purchase or sale.
Lai John reported acquisition or exercise transactions in this Form 4 filing.
PetVivo Holdings, Inc. reported that a corporation owned by Chief Executive Officer John Lai received a grant of restricted common stock as compensation for his past performance. The award covers 66,421 shares of common stock at a stated value of $0.72 per share.
Following this grant, the corporation associated with Lai holds 2,306,913 shares of PetVivo common stock indirectly. This is a compensation-related stock award rather than an open-market purchase or sale, and reflects additional equity granted to an entity affiliated with the CEO.
Rudelius Robert James reported acquisition or exercise transactions in this Form 4 filing.
PetVivo Holdings director Robert James Rudelius purchased 50,000 shares of restricted common stock in a private sale. On April 15, 2026, he bought these shares from another PetVivo shareholder at $0.40 per share, bringing his direct holdings to 403,392 common shares. He also reports indirect ownership of 21,000 common shares held by a corporation.
PetVivo Holdings, Inc. disclosed that A.L. Sarroff Fund, LLC, a ten percent owner, made open-market purchases of its common stock. The fund bought a total of 24,033 shares on March 23, 2026, including 23,033 shares at $0.68 and 1,000 shares at $0.7499 per share. Following these transactions, the fund directly holds 10,202,229 common shares, with Alan L. Sarroff deemed to beneficially own and exercise sole voting and dispositive power over these securities.
Rudelius Robert James reported acquisition or exercise transactions in this Form 4 filing.
PetVivo Holdings, Inc. director Robert James Rudelius received a one-time grant of 35,000 shares of restricted common stock as compensation for prior Board service, valued at $0.74 per share on the grant date. Following this award, he directly holds 353,392 common shares. He also has an additional 21,000 shares reported as indirectly held through a corporation. This Form 4 reflects a compensation-related share grant rather than an open-market purchase or sale.
Ruben Joshua David reported acquisition or exercise transactions in this Form 4 filing.
PetVivo Holdings director Ruben Joshua David reported stock-based compensation grants. He received an aggregate annual grant of 46,332 restricted common shares for Board service, vesting in four installments: 8,832 shares for the pro-rated first quarter and 12,500 shares at the beginning of each subsequent quarter of service.
He also received a one-time grant of 7,500 restricted shares as compensation for prior Board service. Following these awards, he holds 53,832 common shares directly. These are compensation-related grants, not open-market purchases or sales.
PetVivo Holdings, Inc. director Diane M. Levitan reported an acquisition of 15,000 shares of common stock at $0.74 per share. The transaction is coded as a grant or award, meaning these shares were received as compensation rather than bought in the open market.
According to a footnote, this is a one-time grant of 15,000 restricted common shares as compensation for prior Board service. Following this award, Levitan directly owns 71,489 shares of PetVivo common stock.
Jasper Joseph William reported acquisition or exercise transactions in this Form 4 filing.
PetVivo Holdings, Inc. director Jasper Joseph William received a one-time grant of 35,000 shares of restricted common stock as compensation for prior Board service, valued at $0.74 per share on the grant date. Following this award, he directly holds 135,159 common shares, with an additional 2,000 shares held indirectly by his wife. This is a compensation-related equity grant, not an open-market purchase.
Costantino Robert J reported acquisition or exercise transactions in this Form 4 filing.
PetVivo Holdings, Inc. reported that director Robert J. Costantino received a one-time grant of 35,000 shares of restricted common stock as compensation for prior Board service. The grant, valued at $0.74 per share for reporting purposes, increases his direct holdings to 108,661 shares of common stock.
A.L. Sarroff Fund, LLC, a 10% owner of PetVivo Holdings, Inc., reported open-market purchases tied to a unit financing. The fund acquired 1,250,000 Warrants to buy Common Stock with an exercise price of $1.10 per share, expiring on March 13, 2029.
According to the footnotes, these Warrants and 1,250,000 shares of Common Stock were purchased as Units at $0.80 per Unit, with each Unit consisting of one share and one Warrant. Following the stock purchase, the fund holds 10,178,196 Common shares directly.
LOWENTHAL GARRY N reported acquisition or exercise transactions in this Form 4 filing.
PetVivo Holdings, Inc. granted 71,993 shares of restricted common stock at $0.69 per share to a corporation owned by Chief Financial Officer Garry N. Lowenthal as compensation for past performance. These shares are held indirectly, bringing his reported indirect holdings to 812,460 shares.
PetVivo Holdings, Inc. reported that Chief Executive Officer John Lai indirectly acquired 72,282 shares of restricted common stock. The shares were granted to a corporation he owns as compensation for his past performance. Following this award, that corporation’s indirect holdings increased to 2,240,492 common shares.
A.L. Sarroff Fund, LLC, a 10% owner of PetVivo Holdings, Inc., reported a series of acquisitions of PetVivo common stock between October 18 and December 31, 2024. The transactions include numerous open-market purchases coded "P" at prices generally between $0.46 and $0.57 per share, as well as several entries coded "C" at $0.46 per share. After the final reported purchase of 16,001 shares at $0.57 on December 31, 2024, the fund held 7,740,579 shares of PetVivo common stock in direct ownership.
According to a footnote, Alan L. Sarroff is the Chief Executive Officer and Managing Member of A.L. Sarroff Fund, LLC and is deemed to beneficially own and have sole voting and dispositive power over the fund’s securities.
A.L. Sarroff Fund, LLC, a more than 10% owner of PetVivo Holdings, Inc. (PETV), filed a Form 4 detailing extensive insider activity in 2024. The fund reported multiple open-market purchases of PetVivo common stock between April 5 and October 15, 2024 at prices ranging from $0.40 to $1.06 per share, along with several warrant-related transactions, including exercises and new warrant purchases.
These transactions included warrant exercises that delivered shares, such as 770,767 common shares on September 26, 2024, and warrant acquisitions in February, April, May, June, and July 2024. Following the most recent trade on October 15, 2024, the fund directly beneficially owned 6,610,930 shares of PetVivo common stock, with additional common stock and warrants reported as indirectly owned, including securities held by the spouse of Alan L. Sarroff. Alan L. Sarroff is the chief executive officer and managing member of the fund and is deemed to beneficially own and have sole voting and dispositive power over its securities.
A.L. Sarroff Fund, LLC, a 10% owner of PetVivo Holdings, Inc., reported several equity transactions. On October 26, 2023, the fund acquired 164,340 shares of common stock at $0.73 per share, bringing its holdings to 1,748,251 common shares.
On December 15, 2023, the fund purchased an additional 111,112 common shares at $0.90 per share, increasing its position to 1,859,363 common shares. The same day, it bought 111,112 warrants with a $1.50 exercise price, each warrant exercisable for one share of common stock and expiring on December 15, 2026. A footnote states that Alan L. Sarroff, as Chief Executive Officer and Managing Member of the fund, is deemed to beneficially own and have sole voting and dispositive power over the fund’s securities.
PetVivo Holdings’ Chief Financial Officer, Garry Lowenthal, reported an insider stock grant. On 12/11/2025, a corporation he owns received 72,500 shares of restricted common stock at $1.05 per share as compensation for his past performance. After this award, he indirectly beneficially owns 740,467 shares of PetVivo common stock through that corporation.
PetVivo Holdings Chief Executive Officer and director John Lai indirectly acquired 72,500 shares of the company’s common stock on 12/11/2025 at $1.05 per share. The transaction was a grant of restricted common stock to a corporation he owns, provided as compensation for his past performance by converting a previously accrued bonus into equity.
After this award, Lai beneficially owned 2,168,210 shares of PetVivo common stock, held indirectly through the corporation. This increases the portion of his compensation tied to the company’s stock performance.
PetVivo Holdings (PETV) director reports open-market share purchases. Director Robert Rudelius bought three blocks of the company's common stock on 11/24/2025, acquiring 3,000 shares at $1.08, 523 shares at $1.05, and 500 shares at $1.28. The filing states these were routine investment transactions and were not made under any compensatory or issuer-sponsored plan.
Following these transactions, Rudelius beneficially owned 318,392 shares directly and an additional 21,000 shares indirectly through a corporation. This Form 4 reflects his updated ownership position and confirms that the purchases were personal investments in PetVivo Holdings stock.
PetVivo Holdings (PETV) reported an insider transaction on Form 4. Chief Financial Officer Garry Lowenthal received 75,000 shares of restricted common stock on 10/23/2025 at a reported price of $1.27 per share. The grant was issued to a corporation owned by him as compensation for past performance. After this grant, he beneficially owns 667,967 shares, held indirectly through the corporation.
PetVivo Holdings (PETV) reported an insider transaction on a Form 4. CEO and Director John Lai acquired 75,000 shares of common stock on 10/23/2025 at $1.27 per share. The filing states the shares were a grant of restricted common stock to a corporation he owns, as compensation for past performance by converting a past accrued bonus into common stock.
After the transaction, Lai beneficially owned 2,095,710 shares, held indirectly through the corporation.
PetVivo Holdings (PETV) reported an insider equity grant. Director Spencer Breithaupt acquired 12,500 shares of common stock on 10/10/2025 at $1.28 per share. The transaction reflects an annual Board compensation award of 50,000 restricted shares, vesting in four equal quarterly installments of 12,500 at the beginning of each quarter. Following the transaction, Breithaupt beneficially owns 60,187 shares, held directly.
PetVivo Holdings (PETV) reported an insider equity award. Director Diane Levitan acquired 12,500 shares of restricted common stock at $1.28 on 10/10/2025. The award is part of an aggregate annual grant of 50,000 shares for Board service, vesting in four equal installments of 12,500 at the beginning of each quarter.
Following this transaction, Levitan beneficially owns 56,489 shares, held directly.
PetVivo Holdings (PETV) director reported multiple stock grants. On 10/01/2025, the director acquired 14,935 shares of restricted common stock at $1.19 as compensation for prior consulting services. On 10/10/2025, additional restricted stock grants were recorded: 12,500 shares at $1.28 for quarterly Board service vesting, 50,000 shares at $1.28 tied to a warrant exercise with a $25,000 payment to the company, and 100,000 shares at $1.28 tied to a warrant exercise with a $50,000 payment to the company. Following these transactions, beneficial ownership stood at 311,807 shares, held directly.
PetVivo Holdings (PETV) reported a Form 4 for director Robert Rudelius. On 10/10/2025, he acquired 12,500 shares of common stock at $1.28 as part of an annual 50,000 restricted-share board compensation grant that vests in four equal quarterly installments. Following the transaction, he beneficially owned 314,369 shares directly and 21,000 shares indirectly via a corporation.
PetVivo Holdings (PETV) reported a Form 4 showing Director Joseph Jasper acquired 12,500 restricted common shares at $1.28 on 10/10/2025. The transaction reflects the first quarterly vesting from an annual board compensation grant of 50,000 shares, vesting in four equal installments of 12,500 each.
Following the transaction, Jasper beneficially owned 100,159 shares directly, plus 2,000 shares indirectly held by his spouse.
PetVivo Holdings (PETV) disclosed a Form 4 for a director on 10/10/2025, reporting the acquisition of 12,500 shares of common stock at $1.28 per share. Following the transaction, the director beneficially owns 73,661 shares directly.
The filing notes this is part of an aggregate annual grant of 50,000 restricted shares for Board service, vesting in four equal installments of 12,500 shares at the beginning of each quarter.
PetVivo Holdings, Inc. reporting person John Lai, who serves as Chief Executive Officer and a director, reported a non‑derivative acquisition on 09/18/2025. The filing shows a grant of 84,375 shares of common stock at a price of $0.76 to a corporation owned by the reporting person as compensation for past performance, reflecting conversion of a past accrued bonus into common stock. Following the transaction, the reporting person (indirectly) beneficially owned 2,020,710 shares. The Form 4 is signed by John Lai on 09/22/2025. The filing indicates the award was issued as compensation rather than a market purchase.
Garry Lowenthal, Chief Financial Officer of PetVivo Holdings, Inc., received a grant of restricted common stock on 09/18/2025 as compensation for past performance. The grant consisted of 79,375 shares at a stated price of $0.76 and was issued to a corporation owned by Mr. Lowenthal. After the reported transaction, the reporting persons indirect beneficial ownership totaled 592,967 shares. The Form 4 indicates this was a non-derivative award recorded as an acquisition and identifies the grant as compensation rather than a market purchase.